GHS’ Rebate Services

Effective June 4th, the 2 Peachtree St building that houses the Deprtment of Community Health will implement a new security procedure.  Visitors will be required to present a valid photo ID (driver's license, military ID, or other government issued ID cards).  The security officer will issue a visitor's ID with a photo that will be worn on one's clothing.  The visitory ID must be displayed at all times.  The visitor ID is valid for one business day (6am-6pm) and will automatically expire.  Before being allowed through the turnstile, all visitors with carry-on items will still be required to place those items through the X-ray machine in accordance with current access control policy.  DCH requests that visitors attending the DUR Board meetings please arrive early in order to comply with these new requirements and still be ale to access the meeting in a timely manner.  DCH appreciates your assistance in complying with this new requirement.

 

Goold Health Systems (GHS) provides Medicaid Drug Rebate Services for the State of Georgia Department of Community Health (DCH).

Rebate services include:

  • Invoice processing, collections, and reconciliation of OBRA, Supplemental, and J-Code rebates;
  • Dispute avoidance and dispute resolution;
  • Negotiating for supplemental and State special rebates for Georgia as a single state; and
  • Reporting services.

GHS is a national leader in providing Drug Rebate Administration to state Medicaid programs. GHS has over 35 years of experience with Pharmacy Benefit Services Administration (PBSA) solutions, including 13 years of drug rebate administration.

The drug rebate process is a core function of GHS’s Medicaid pharmacy benefit services. GHS partners with State Medicaid Agencies to deliver cost-effective and compliant Rebate Services that lower overall Medicaid prescription drug costs.

GHS practices transparent pharmacy benefits practices. One hundred percent of the rebates we negotiate for our State clients go directly to federal and state governments to offset their drug-spend costs.